Prevalence and management of coeliac disease in people with Down’s syndrome
Intended for healthcare professionals
Evidence & Practice    

Prevalence and management of coeliac disease in people with Down’s syndrome

Lynette Harper Senior lecturer, Learning disability nursing, Kingston University and St George’s University of London, England

People with Down’s syndrome are more likely to have additional health complications than the general population, including coeliac disease. It is important to monitor people for signs and symptoms of the condition and complete further assessments as required. A gluten-free diet is best practice in management of coeliac disease and this article provides information on how to support people with Down’s syndrome to adhere to this diet. The article also describes the increased incidence of coeliac disease in people with Down’s syndrome, how support staff and carers can monitor for signs or symptoms of the condition, and how to support early identification through screening. It also discusses treatment of coeliac disease and the monitoring required for improved health outcomes.

Learning Disability Practice. 21, 3, 24-27. doi: 10.7748/ldp.2018.e1889


Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Conflict of interest

None declared


To reuse this article or for information about reprints and permissions, please contact

Write for us

For information about writing for RCNi journals, contact

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now